SCHEMBL17433119

SCHEMBL17433119

c1ccc2c(c1)oc1c(-n3c4ccccc4c4c5ccc6c7ccccc7oc6c5ccc43)cccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP2C19 P33261 1/20 0.36
ALOX5 P09917 3/20 0.35
DYRK1A Q13627 1/20 0.33
AHR P35869 2/20 0.33
ALDH1A1 P00352 2/20 0.33
PRKDC P78527 3/20 0.32
DRD4 P21917 1/20 0.32
MAOA P21397 1/20 0.32
PGR P06401 1/20 0.32
CDC25A P30304 1/20 0.31
CDC25B P30305 1/20 0.31
CDC25C P30307 1/20 0.31
KDM5A P29375 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
PTGS2 P35354 1/20 0.31
PIK3CD O00329 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15137652 0.93 MEN1 (0.37) MEN1KMT2ACYP2C19ALOX5AHR
SCHEMBL18086132 0.93 MEN1 (0.39) MEN1KMT2ACYP2C19ALOX5AHR
SCHEMBL17990249 0.92 KDM4E (0.42) MEN1KMT2ACYP2C19ALOX5ALDH1A1
SCHEMBL16483877 0.91 MEN1 (0.36) MEN1KMT2ACYP2C19ALOX5AHR
SCHEMBL16791481 0.90 ALDH1A1 (0.35) MEN1KMT2ACYP2C19ALOX5DYRK1A
SCHEMBL21671075 0.88 MEN1 (0.38) MEN1KMT2ACYP2C19ALOX5AHR
SCHEMBL17433077 0.88 KDM4E (0.39) MEN1KMT2ACYP2C19ALDH1A1KDM4E
SCHEMBL14886500 0.87 ALOX5 (0.34) MEN1KMT2ACYP2C19ALOX5AHR
SCHEMBL15804118 0.87 MEN1 (0.36) MEN1KMT2ACYP2C19ALOX5AHR
SCHEMBL18967709 0.87 ALOX5 (0.37) MEN1KMT2ACYP2C19ALOX5AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9806271-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2017-10-31 US disclosed
US-9806271-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2017-10-31 US disclosed
US-20170162797-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-06-08 US disclosed
US-20170162797-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-06-08 US disclosed
WO-2016006959-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2016-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170162797-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME L1CAM, CHRM1, OR10J3 MEN1 704/4885KMT2A 2735/4885CYP2C19 557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.